Objective To investigate the long- term efficacy and safety for cyclosporine A( Cs A) in renal transplant recipients. Methods A total of 2332 kidney recipients were divided into three groups( 1) children( < 18 years of age)( GI,n = 27);( 2) adults( 18 to 60 ys)( GII,n = 2 086); and( 3) elderly recipients( > 60 ys)( GIII,n =219); Information was obtained on acute rejection( AR),chronic rejection( CR),side effect,patient and graft survival at 1,3,5 and 10 years. Data were compared among the three groups,with ...